Yulun Wang, Head of Research & Development at Teladoc Health, Inc. (TDOC), sold 8,000 shares at $226.66 ($1.8M) on 2021-01-14, disclosed to the SEC on 2021-01-19.
Open-market sale of $1.8M TDOC by Head of Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TDOC | SELL | 2021-01-22 | $1.9M | — | Filing → |
| TDOC | SELL | 2020-12-16 | $498K | — | Filing → |
| TDOC | SELL | 2020-12-07 | $1.2M | — | Filing → |